ALLMedicine™ Prostatic Hyperplasia Center

Aug 2nd, 2022 - This project attempts to clarify the expression of MUS81 in castration-resistant prostate cancer (CRPC) and the effect on drug sensitivity to Olaparib. We collected clinical surgical samples of patients who were suffering from benign prostatic hyp...

Aug 2nd, 2022 - Benign prostatic hyperplasia (BPH) is a nonmalignant growth of the prostate tissue and causes urinary tract symptoms. To provide effective treatment, tamsulosin (TM), saw palmetto oil (SP), and pumpkin seed oil (PSO) were combined and fabricated a...

Aug 1st, 2022 - Because of many unanswered questions regarding men's health, a literature review was performed to better understand the role of testosterone and testosterone replacement therapy (TRT) in the management of hypogonadism and aging related prostate gl...

Jul 30th, 2022 - With the ubiquity of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) in older men, costs related to this highly prevalent disease are likely significant but not well defined. With this study, we hoped to define costs re...

Jul 29th, 2022 - The aim of this study was to elucidate the role of NF-κB activation in benign prostatic hyperplasia (BPH) using immunohistochemistry. Immunohistochemical staining for NF-κB was performed and evaluated, dividing into glands and stroma in 101 human ...

Aug 14th, 2021 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are p...

Jul 24th, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...

May 7th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Mar 12th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

May 9th, 2022 - NEW YORK (Reuters Health) - Aquablation appears to be a safe and effective for treatment for lower-urinary-tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), regardless of prostate volume, new data show. Aquablation using the AquaBea...

Mar 7th, 2022 - NEW YORK (Reuters Health) - Rezum water vapor thermal therapy was safe and effective in patients with benign prostatic hyperplasia (BPH), in a registry study. "This prospectively collected registry of real-world cases shows Rezum to be a fast, eff...

Feb 24th, 2022 - In the largest study of its kind, a series of 9-second shots with barely boiling water into enlarged prostates appears to be a safe and effective approach to treating benign prostatic hyperplasia (BPH), a Canadian-American team reported in the jou...

Jan 20th, 2022 - This transcript has been edited for clarity. I'm Dr Neil Skolnik. Today, I'm going to talk about the American Urologic Association's new guidelines on the management of lower urinary tract symptoms, also called LUTS, due to benign prostatic hyperp...

Sep 1st, 2021 - The American Urological Association (AUA) has updated its guidelines on managing male lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH). The updates, the first since 2010, were summarized in the Journal of Urolog...